Cargando…

Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data

PURPOSE: Pathologic downstaging of rectal cancer has been suggested to be associated with the time interval from chemoradiotherapy (CRT) completion to surgery. We aimed to evaluate the effect of this time interval for patients with rectal cancer on the pathologic response. METHODS: All patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min Jung, Cho, Jin Suk, Kim, Eun Mi, Ko, Woo Ah, Oh, Jae Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Coloproctology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238805/ https://www.ncbi.nlm.nih.gov/pubmed/30419721 http://dx.doi.org/10.3393/ac.2018.01.01

Ejemplares similares

Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer
por: Lee, Hyebin, et al.
Publicado: (2012)

Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
por: Kim, Chang Hyun
Publicado: (2018)

Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
por: Oh, Bo Young, et al.
Publicado: (2022)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Are We Predicting Disease Progress of the Rectal Cancer Patients without Surgery after Neoadjuvant Chemoradiotherapy?
por: Oh, Bo Young, et al.
Publicado: (2018)

Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer
por: Lee, Soo Young, et al.
Publicado: (2022)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2011)

Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy
por: Shim, Byoung Yong, et al.
Publicado: (2016)

Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Yoo, Ri Na, et al.
Publicado: (2019)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer
por: Lee, Hee Yeon, et al.
Publicado: (2015)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study
por: Rombouts, A. J. M., et al.
Publicado: (2016)

Is long interval from neoadjuvant chemoradiotherapy to surgery optimal for rectal cancer in the era of intensity-modulated radiotherapy?: a prospective observational study
por: Chang, Hui, et al.
Publicado: (2018)

Clinical influence of neoadjuvant chemoradiotherapy on immunonutritional status in locally advanced rectal cancer
por: Lee, Soohyeon, et al.
Publicado: (2023)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Serbanescu, GL, et al.
Publicado: (2017)

Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy
por: Song, Kwang-Seop, et al.
Publicado: (2019)

Optimized Parameters of Diffusion-Weighted MRI for Prediction of the Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Jie, et al.
Publicado: (2019)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
por: Tokuhara, Katsuji, et al.
Publicado: (2016)

Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients
por: Jung, Ji-Han, et al.
Publicado: (2016)

Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?
por: Glimelius, Bengt
Publicado: (2014)

Minimally invasive versus open intersphincteric resection of low rectal cancer regardless of neoadjuvant chemoradiotherapy: long-term oncologic outcomes
por: Shin, Jung kyong, et al.
Publicado: (2021)

Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Single-Center Experience and Literature Review
por: Kim, Min Chul, et al.
Publicado: (2021)

Short-Term Clinical and Oncological Outcome of Prolonging Operation Interval After Neoadjuvant Chemoradiotherapy for Locally Advanced Middle and Low Rectal Cancer
por: Yang, Jianguo, et al.
Publicado: (2020)

Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis
por: Wang, Xiao-Jie, et al.
Publicado: (2016)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Travaini, Laura L, et al.
Publicado: (2016)

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Toomey, Sinead, et al.
Publicado: (2020)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy
por: Joo, Jung Il, et al.
Publicado: (2021)

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
por: Kim, Min Jung, et al.
Publicado: (2023)

Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study
por: Luo, Dakui, et al.
Publicado: (2023)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer
por: Pyo, Dae Hee, et al.
Publicado: (2021)

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
por: Chang, Hui, et al.
Publicado: (2020)

Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Zhang, Chongda, et al.
Publicado: (2017)

Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer
por: Huang, Yan, et al.
Publicado: (2019)

Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
por: Zhang, Yiyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n9mvrkhefsm08m8kipor3td2g0